- Home
- RVP vs KZR Comparison
RVP vs KZR Comparison
Compare RVP & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVP
- KZR
- Stock Information
- Founded
- RVP 1994
- KZR 2015
- Country
- RVP United States
- KZR United States
- Employees
- RVP N/A
- KZR N/A
- Industry
- RVP Medical/Dental Instruments
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- RVP Health Care
- KZR Health Care
- Exchange
- RVP Nasdaq
- KZR Nasdaq
- Market Cap
- RVP 25.1M
- KZR 29.7M
- IPO Year
- RVP 2001
- KZR 2018
- Fundamental
- Price
- RVP $0.87
- KZR $3.92
- Analyst Decision
- RVP
- KZR Hold
- Analyst Count
- RVP 0
- KZR 2
- Target Price
- RVP N/A
- KZR $9.00
- AVG Volume (30 Days)
- RVP 59.3K
- KZR 39.9K
- Earning Date
- RVP 11-13-2025
- KZR 11-11-2025
- Dividend Yield
- RVP N/A
- KZR N/A
- EPS Growth
- RVP N/A
- KZR N/A
- EPS
- RVP N/A
- KZR N/A
- Revenue
- RVP $38,161,712.00
- KZR N/A
- Revenue This Year
- RVP N/A
- KZR N/A
- Revenue Next Year
- RVP N/A
- KZR N/A
- P/E Ratio
- RVP N/A
- KZR N/A
- Revenue Growth
- RVP N/A
- KZR N/A
- 52 Week Low
- RVP $0.56
- KZR $3.56
- 52 Week High
- RVP $0.89
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- RVP 63.46
- KZR 52.09
- Support Level
- RVP $0.80
- KZR $3.56
- Resistance Level
- RVP $0.88
- KZR $3.96
- Average True Range (ATR)
- RVP 0.03
- KZR 0.20
- MACD
- RVP 0.00
- KZR 0.02
- Stochastic Oscillator
- RVP 83.33
- KZR 66.67
About RVP Retractable Technologies Inc.
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.